Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Surfactant application during spontaneous breathing with CPAP vs mechanical ventilation in IRDS in premature infants <27 weeks
2008-000896-30Phase 4Completed
- Sponsor
- University of Cologne
- Start
- Jan 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of Poractant alfa in respiratory distress syndrome (RDS) (2 arms), sponsored by University of Cologne. Primary endpoint: Survival until term without chronic lung disease (CLD). Started Jan 2009; status: completed.
02
Drugs
Poractant alfa
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on 2008-000896-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000896-30.